Cargando…
Rituximab‐induced acute lympholysis and pancytopenia after COVID‐19 vaccination
Rituximab and COVID‐19 vaccine can cause massive hyperacute depletion of B cells and plasma cells, as well as subsequent cytokine release syndrome, coagulopathy, and pancytopenia. These effects differ from the adverse effects that have been reported for rituximab, and new guidelines regarding the ti...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365555/ https://www.ncbi.nlm.nih.gov/pubmed/34429981 http://dx.doi.org/10.1002/ccr3.4517 |